It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
After spinal cord injury (SCI), inflammatory cells such as macrophages infiltrate the injured area, and astrocytes migrate, forming a glial scar around macrophages. The glial scar inhibits axonal regeneration, resulting in significant permanent disability. However, the mechanism through which glial scar-forming astrocytes migrate to the injury site has not been clarified. Here we show that migrating macrophages attract reactive astrocytes toward the center of the lesion after SCI. Chimeric mice with bone marrow lacking IRF8, which controls macrophage centripetal migration after SCI, showed widely scattered macrophages in the injured spinal cord with the formation of a huge glial scar around the macrophages. To determine whether astrocytes or macrophages play a leading role in determining the directions of migration, we generated chimeric mice with reactive astrocyte-specific Socs3−/− mice, which showed enhanced astrocyte migration, and bone marrow from IRF8−/− mice. In this mouse model, macrophages were widely scattered, and a huge glial scar was formed around the macrophages as in wild-type mice that were transplanted with IRF8−/− bone marrow. In addition, we revealed that macrophage-secreted ATP-derived ADP attracts astrocytes via the P2Y1 receptor. Our findings revealed a mechanism through which migrating macrophages attract astrocytes and affect the pathophysiology and outcome after SCI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Kyushu University, Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849)
2 Kyushu University, Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); Kyushu University, Kyushu University Institute for Advanced Study, Fukuoka-shi, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849)
3 Yokohama City University Graduate School of Medicine, Department of Immunology, Kanazawa-ku, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139)
4 NICHD, National Institutes of Health, Program in Genomics of Differentiation, Section on Molecular Genetics of Immunity, Division of Developmental Biology, Bethesda, USA (GRID:grid.420089.7) (ISNI:0000 0000 9635 8082)
5 Kyushu University, Kyushu University Institute for Advanced Study, Fukuoka-shi, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849); Kyushu University, Greenpharma Research Center for System Drug Discovery, Fukuoka, Japan (GRID:grid.177174.3) (ISNI:0000 0001 2242 4849)
6 Kindai University, Department of Energy and Materials, Faculty of Science and Engineering, Osaka, Japan (GRID:grid.258622.9) (ISNI:0000 0004 1936 9967)
7 Spinal Injuries Center, Department of Orthopaedic Surgery, Iizuka, Japan (GRID:grid.419662.e) (ISNI:0000 0004 0640 6546)
8 Osaka University, Department of Orthopaedic Surgery, Graduate School of Medicine, Suita, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)